Clinical Trial Update: Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of a hematinic agent for postpartum anemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Anemia

Drugs mentioned

• Hematinic Agent

Snippet

Sponsor: American Regent, Inc. | Conditions: Postpartum Anemia | Phase 3 | Status: COMPLETED | Results posted: 2013-12-05